Control of dysfunctional Tregs
控制功能失调的 Tregs
基本信息
- 批准号:10335230
- 负责人:
- 金额:$ 48.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAddressAdultAgeAllograftingApoptosisAreaAutoimmune DiseasesAutoimmunityBindingBiogenesisBiological AssayBiologyBone Marrow TransplantationCellsChIP-seqChromatinClinicalComplexDevelopmentEragrostisFOXP3 geneFamilyFamily memberFluorescenceFunctional disorderFundingGenetic TranscriptionGoalsImmuneImmune ToleranceImmunosuppressionInterleukin 2 ReceptorInterleukin-2JAK3 geneKnowledgeLoxP-flanked alleleMalignant NeoplasmsMediatingMessenger RNAModelingMotorMusMutationOrgan TransplantationPathway interactionsPatientsPeripheralPharmaceutical PreparationsPhenotypePositioning AttributeProteinsRNARNA BindingRNA HelicaseRNA ProcessingRNA SplicingRNA immunoprecipitation sequencingRNA-Binding ProteinsRegulationRegulatory T-LymphocyteReporterReportingRibosomesRoleSignal TransductionSiteSpliceosomesStat5 proteinSystemTestingThymus GlandTimeToxic effectTranscription Factor AP-1TranslatingTransplant RecipientsTransplantationTransplantation ToleranceUntranslated Regionsactivation productaspartylglutamatebasechromatin remodelingdesigneffector T cellgenome-wideglutamylalaninehelicasein vivoinflammatory milieuknock-downmRNA PrecursormRNA Stabilitymembernoveloverexpressionprogramsreceptorsensorsignature moleculesingle-cell RNA sequencingstress granuletooltranscription factortranscriptometranscriptome sequencingtransplantation therapyviral RNA
项目摘要
Project Summary
Rejection remains a major hurdle to long lasting transplant survival and we aspire to uncover the
fundamental mechanisms that hinder stable allograft survival. In the last funding period, we studied the
mechanisms of Treg dysfunctions and identified BATF and BATF3 as potent repressors of Foxp3,
suppressing Foxp3 expression and Treg induction. These studies also led to the discovery of the DHX15
helicase as a critical regulator of Foxp3+Tregs, as conditional deletion of Dhx15 in Tregs resulted in a
profound depletion of Tregs in the periphery and lethal autoimmune diseases. In essence, DHX15 is an
RNA helicase (an RNA binding motor protein) and traditionally thought to be involved in RNA processing. Its
roles in the control of Tregs are unexpected and clearly reveal novel previously unknown aspects of Tregs
that are different from currently known mechanisms, and uncovering those mechanisms is the central goal
of this proposal.
Our working hypothesis is that DHX15 controls Treg identity and/or survival at peripheral sites and that its
deficiency results in either their reversion to Teff or die of apoptosis. We surmise that DHX15 may also
control Tregs at the graft site, where they must overcome the inflammatory milieu to exert suppressive
functions. We proposed 3 Aims to test this hypothesis in this application: the first Aim is to test whether
DHX15 controls Treg identity by acting as an RNA splicing factor, processing mRNAs that encode the
Foxp3 or Foxp3 controlled signature molecules in Tregs, the second Aim is to address whether DHX15
controls Tregs survival by regulating the IL-2 signaling complex, such that Tregs die of apoptosis in its
absence, and the third Aim is to examine whether DHX15 is especially important for Tregs at graft sites
where they are needed the most in promoting transplant tolerance. Overall, DHX15 is the first RNA helicase
identified thus far that controls Tregs, and the genetically modified models as well as cutting-edge
approaches we have developed put us in a unique position in dissecting mechanistically how the DHX15
helicase acts in regulating Tregs, an area of considerable importance in both basic Treg biology and Treg-
based therapies.
项目摘要
排斥反应仍然是长期移植存活的主要障碍,我们渴望揭示
阻碍同种异体移植物稳定存活的基本机制。在上一个资助期内,我们研究了
Treg功能障碍的机制,并将BATF和BATF 3鉴定为Foxp 3的有效阻遏物,
抑制Foxp 3表达和Treg诱导。这些研究也导致了DHX 15的发现。
解旋酶作为Foxp 3 + TcR的关键调节因子,因为TcR中Dhx 15的条件性缺失导致
外周和致命性自身免疫性疾病中Tcl 3的严重消耗。从本质上讲,DHX 15是一个
RNA解旋酶(一种RNA结合马达蛋白),传统上认为与RNA加工有关.其
在控制TdR中的作用是出乎意料的,并清楚地揭示了TdR以前未知的新方面
与目前已知的机制不同,而揭示这些机制是中心目标
这一提议。
我们的工作假设是DHX 15控制外周部位的Treg身份和/或存活,
缺乏导致它们回复到Teff或死于细胞凋亡。我们推测DHX 15也可能
控制移植部位的THP,在那里它们必须克服炎症环境以施加抑制性作用。
功能协调发展的我们提出了3个目的来测试这个假设在这个应用程序中:第一个目的是测试是否
DHX 15通过充当RNA剪接因子,加工编码调节性T细胞的mRNA,
Foxp 3或Foxp 3控制的标签分子,第二个目的是解决DHX 15
通过调节IL-2信号复合物来控制TcR的存活,使得TcR在其细胞凋亡中死亡。
第三个目的是检查DHX 15是否对移植部位的THP特别重要
在最需要它们的地方促进移植耐受性。DHX 15是第一个RNA解旋酶,
到目前为止,已经确定了控制Tibet的基因,以及转基因模型和尖端技术。
我们开发的方法使我们处于一个独特的位置,可以机械地剖析DHX 15
解旋酶在调节Treg中起作用,Treg是基础Treg生物学和Treg生物学中相当重要的领域。
基础疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xian Chang Li其他文献
An update on regulatory T cells in transplant tolerance and rejection
移植耐受与排斥中调节性 T 细胞的最新进展
- DOI:
10.1038/nrneph.2010.101 - 发表时间:
2010-08-03 - 期刊:
- 影响因子:39.800
- 作者:
Xian Chang Li;Laurence A. Turka - 通讯作者:
Laurence A. Turka
Vascularized Composite Allotransplantation Research: The Emerging Field
血管化复合同种异体移植研究:新兴领域
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:8.8
- 作者:
Bohdan Pomahac;Yolanda T. Becker;L. Cendales;S. Ildstad;Xian Chang Li;S. Schneeberger;M. Siemionow;A. Thomson;Xin Xiao Zheng;Stefan G. Tullius - 通讯作者:
Stefan G. Tullius
IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.
IL-2 受体靶向细胞溶解性 IL-2/Fc 融合蛋白治疗可阻断非肥胖糖尿病小鼠的糖尿病性自身免疫。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:4.4
- 作者:
X. Zheng;A. Steele;Wayne W. Hancock;Kensaku Kawamoto;Xian Chang Li;Peter W. Nickerson;Yongsheng Li;Yan Tian;Terry B. Strom - 通讯作者:
Terry B. Strom
Facile synthesis of rare earth ions doped LiSrsub4/sub(BNsub2/sub)sub3/sub phosphors for white light-emitting diodes
用于白光发光二极管的稀土离子掺杂的 LiSr₄(BN₂)₃ 荧光粉的简便合成
- DOI:
10.1016/j.jallcom.2024.175052 - 发表时间:
2024-09-15 - 期刊:
- 影响因子:6.300
- 作者:
Wenqin Luo;Yongya Wang;Xian Chang Li;Haiyan Wu - 通讯作者:
Haiyan Wu
Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4-dependent and independent pathways.
血液单核细胞向急性肺部炎症的迁移涉及 CD11/CD18 和非常晚期激活抗原 4 依赖性和独立途径。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:4.4
- 作者:
Xian Chang Li;Masayuki Miyasaka;T. Issekutz - 通讯作者:
T. Issekutz
Xian Chang Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xian Chang Li', 18)}}的其他基金
Modulation of innate immune cells to create transplant tolerance
调节先天免疫细胞以产生移植耐受
- 批准号:
8078381 - 财政年份:2011
- 资助金额:
$ 48.45万 - 项目类别:
Modulation of innate immune cells to create transplant tolerance
调节先天免疫细胞以产生移植耐受
- 批准号:
8232053 - 财政年份:2011
- 资助金额:
$ 48.45万 - 项目类别:
Modulation of innate immune cells to create transplant tolerance
调节先天免疫细胞以产生移植耐受
- 批准号:
8628733 - 财政年份:2011
- 资助金额:
$ 48.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.45万 - 项目类别:
Research Grant